IceCure Medical Ltd

ICCM | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.95

$0 (0.00%)

Sep 22, 2026, 12:29 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.00%

(1D)

Rating

Updated: Sep 8, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $4.39M

1D Range

1.95 2.04

52W Range

1.95 42

Valuation (TTM)

PE -0.29

PB 0.37

EV/EBITDA 0.46

Valuation (NTM)

Forward PE N/A

Forward PEG 0.01

Price Target $1

Cash Flow

FCF Yield -373.2%

SBC Adj. FCF Yield -394.3%

SBC Impact -5.7%

Margins

Gross Margin 36.1%

Operating Margin -556.4%

FCF Margin -415.2%

Growth (CAGR)

Revenue 3Y | 5Y 7.0% | -0.7%

Dil EPS 3Y | 5Y 13.1% | 16.2%

FCF 3Y | 5Y -18.4% | 0.7%

Returns

ROA -95.3%

ROE -174.3%

ROIC -183.2%

Financial Health

Net Cash

$12.03M

Current Ratio 2.87

Interest Coverage -139.87

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumor...

Sector Healthcare

Industry Medical - Devices

Employees 68

IPO Date Aug 25, 2021

Website www.icecure-medical.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 18, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Downside

-48.72%

Buy (2)

Hold (0)

Sell (0)

Analyst Details ➞